TrialOxidative medicine and cellular longevity2022

Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial.

Sarfraz Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.